Eluxadoline
Eluxadoline, sold under the brand names Viberzi and Truberzi, is a medication taken by mouth for the treatment of diarrhea and abdominal pain in individuals with diarrhea-predominant irritable bowel syndrome (IBS-D). It was approved for use in the United States in 2015. The drug originated from Janssen Pharmaceutica and was developed by Actavis.
primaryTopic
Eluxadoline
Eluxadoline, sold under the brand names Viberzi and Truberzi, is a medication taken by mouth for the treatment of diarrhea and abdominal pain in individuals with diarrhea-predominant irritable bowel syndrome (IBS-D). It was approved for use in the United States in 2015. The drug originated from Janssen Pharmaceutica and was developed by Actavis.
has abstract
Eluxadoline, sold under the br ...... and was developed by Actavis.
@en
alternative name
Viberzi, Truberzi
@en
CAS number
864821-90-9
FDA UNII code
45TPJ4MBQ1
KEGG
PubChem
Wikipage page ID
46,829,735
page length (characters) of wiki page
Wikipage revision ID
1,016,045,258
Link from a Wikipage to another Wikipage
ATC prefix
A07
@en
ATC suffix
DA06
@en
CAS number
ChemSpiderID
elimination half-life
excretion
image
@en
IUPAC name
IUPHAR ligand
KEGG
D10403
@en
legal US
Schedule IV
@en
licence EU
yes
@en
pronounce
Viberzi
@en
protein bound
PubChem
11,250,029
routes of administration
By mouth
@en
SMILES
CC1=CCCN
@en
StdInChIKey
QFNHIDANIVGXPE-FNZWTVRRSA-N
@en
synonyms
JNJ-27018966
@en
tradename
Viberzi, Truberzi
@en
wikiPageUsesTemplate
subject
hypernym
comment
Eluxadoline, sold under the br ...... and was developed by Actavis.
@en
label
Eluxadoline
@en